These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17220410)

  • 1. Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases.
    Thomson JM; Prati F; Bethel CR; Bonomo RA
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1577-9. PubMed ID: 17220410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
    Ke W; Sampson JM; Ori C; Prati F; Drawz SM; Bethel CR; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2011 Jan; 55(1):174-83. PubMed ID: 21041505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design.
    Rojas LJ; Taracila MA; Papp-Wallace KM; Bethel CR; Caselli E; Romagnoli C; Winkler ML; Spellberg B; Prati F; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1751-9. PubMed ID: 26729496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog.
    Curtis BN; Smolen KA; Barlow SJ; Caselli E; Prati F; Taracila MA; Bonomo RA; Wallar BJ; Powers RA
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.
    Caselli E; Romagnoli C; Vahabi R; Taracila MA; Bonomo RA; Prati F
    J Med Chem; 2015 Jul; 58(14):5445-58. PubMed ID: 26102369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of FOX-4 Cephamycinase in Complex with Transition-State Analog Inhibitors.
    Lefurgy ST; Caselli E; Taracila MA; Malashkevich VN; Biju B; Papp-Wallace KM; Bonanno JB; Prati F; Almo SC; Bonomo RA
    Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32349291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boronic acid inhibitors of the class A β-lactamase KPC-2.
    Zhou J; Stapleton P; Haider S; Healy J
    Bioorg Med Chem; 2018 Jul; 26(11):2921-2927. PubMed ID: 29784271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.
    Nguyen NQ; Krishnan NP; Rojas LJ; Prati F; Caselli E; Romagnoli C; Bonomo RA; van den Akker F
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1760-6. PubMed ID: 26729491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases].
    Bedenić B; Boras A
    Lijec Vjesn; 2001; 123(11-12):293-6. PubMed ID: 11930754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase].
    Bercion R; Meyran M; Labia R; Thabaut A
    Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.
    Tan Q; Ogawa AM; Painter RE; Park YW; Young K; DiNinno FP
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2622-4. PubMed ID: 20299220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.
    Pattanaik P; Bethel CR; Hujer AM; Hujer KM; Distler AM; Taracila M; Anderson VE; Fritsche TR; Jones RN; Pagadala SR; van den Akker F; Buynak JD; Bonomo RA
    J Biol Chem; 2009 Jan; 284(2):945-53. PubMed ID: 18955486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses.
    Alsenani TA; Rodríguez MM; Ghiglione B; Taracila MA; Mojica MF; Rojas LJ; Hujer AM; Gutkind G; Bethel CR; Rather PN; Introvigne ML; Prati F; Caselli E; Power P; van den Akker F; Bonomo RA
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0093022. PubMed ID: 36602311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.
    Bouza AA; Swanson HC; Smolen KA; VanDine AL; Taracila MA; Romagnoli C; Caselli E; Prati F; Bonomo RA; Powers RA; Wallar BJ
    ACS Infect Dis; 2018 Mar; 4(3):325-336. PubMed ID: 29144724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.
    Levasseur P; Girard AM; Miossec C; Pace J; Coleman K
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1931-4. PubMed ID: 25583732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
    Chen Y; Shoichet B; Bonnet R
    J Am Chem Soc; 2005 Apr; 127(15):5423-34. PubMed ID: 15826180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.